Patent · US Active

Etanercept formulations stabilized with meglumine

US10485869B2 · kind B2 · utility

6Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2012
Grant dateNov 26, 2019
Priority date
Expiry dateOct 18, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.